New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 12, 2014
10:31 EDTGMCR, CHTP, HZNP, OLED, NSROptions with decreasing implied volatility: CHTP NSR HZNP GMCR OLED
News For CHTP;NSR;HZNP;GMCR;OLED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
18:43 EDTOLEDOn The Fly: After Hours Movers
Subscribe for More Information
16:30 EDTOLEDUniversal Display reports Q4 EPS 28c, consensus 32c
Subscribe for More Information
06:07 EDTGMCRDunkin' Brands, J.M. Smucker, Keurig expand partnership
Subscribe for More Information
February 23, 2015
08:03 EDTGMCRKeurig Green Mountain announces repurchase of shares held by Lavazza
Subscribe for More Information
February 20, 2015
11:07 EDTGMCRKeurig Green Mountain spikes higher, levels to watch
Subscribe for More Information
10:49 EDTGMCRGreen Mountain Coffee calls active on renewed takeover chatter
Subscribe for More Information
10:42 EDTGMCRRumor: Keurig Green Mountain moves up on renewed takeover chatter
Shares of Keurig Green Mountain (GMCR) are moving higher on renewed speculation Coca-Cola (KO) may acquire the rest of the company.
10:20 EDTHZNPHigh option volume stocks
Subscribe for More Information
07:08 EDTHZNPAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
February 19, 2015
09:02 EDTGMCRKeurig Green Mountain reiterates FY15 EPS view of growth of mid-single digits
Subscribe for More Information
February 17, 2015
07:15 EDTGMCRConsumer Analyst Group of New York (CAGNY) to hold a conference
Subscribe for More Information
February 13, 2015
13:50 EDTGMCRKeurig Green Mountain moves higher after Coke raises stake
Subscribe for More Information
13:42 EDTGMCRCoca-Cola raises stake in Keurig Green Mountain to 16%
On February 11, Credit Suisse delivered to the Coca-Cola's (KO) Atlantic Industries about 6.38M shares of Keurig Green Mountain (GMCR) common stock pursuant to a previously disclosed letter agreement, dated as of May 12, 2014, between Atlantic and CS for a total acquisition cost of about $830.37M. All such purchases were made using Atlantic's cash on hand, a regulatory filing showed.
11:29 EDTGMCRJ.M. Smucker trades higher despite cautious comments on Q4, FY15
Subscribe for More Information
08:11 EDTHZNPHorizon Pharma submits IND application for ACTIMMUNE
Horizon Pharma announced it has submitted an Investigational New Drug, or IND, application to the FDA for ACTIMMUNE in the treatment of Friedreich's Ataxia, or FA. The company has simultaneously requested Fast Track Designation. The company plans to begin a Phase 3 study in Q2 in collaboration with the Friedreich's Ataxia Research Alliance, or FARA, and the investigators and clinics of FARA's Collaborative Clinical Research Network, or CCRN, in FA.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use